Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080019 | SCV000111913 | uncertain significance | not provided | 2014-08-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000146990 | SCV000194327 | benign | not specified | 2019-06-12 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000080019 | SCV000281540 | likely benign | not provided | 2016-02-18 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000146990 | SCV000514009 | benign | not specified | 2015-09-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002316238 | SCV000851902 | benign | Inborn genetic diseases | 2017-08-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000080019 | SCV001013639 | benign | not provided | 2023-12-22 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002251969 | SCV002523609 | likely benign | See cases | 2020-03-11 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BS1, BP4 |
Prevention |
RCV003935040 | SCV004755906 | likely benign | OPHN1-related condition | 2019-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000080019 | SCV001798031 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000080019 | SCV001932604 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000080019 | SCV001966208 | likely benign | not provided | no assertion criteria provided | clinical testing |